NASDAQ:ASMB
Assembly Biosciences, Inc.
- Stock
Last Close
31.21
06/11 21:00
Market Cap
87.76M
Beta: 0.68
Volume Today
16.82K
Avg: 236.76K
PE Ratio
−0.74
PFCF: −0.93
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 0.50 - | ||||||||||
average payables | 1.76M - | 1.14M 35.52% | 1.87M 64.30% | 2.25M 20.37% | 2.91M 29.49% | 2.71M 6.76% | 3.16M 16.69% | 3.63M 14.66% | 2.58M 29.01% | 1.48M 42.66% | |
average receivables | 1.14M - | 2.35M 106.89% | 2.90M 23.40% | 2.30M 20.68% | 783K 65.99% | 640K 18.26% | 493.50K 22.89% | ||||
book value per share | 8.37 - | 7.56 9.64% | 4.64 38.68% | 6.37 37.43% | 9.24 44.97% | 10.40 12.62% | 6.79 34.73% | 3.90 42.52% | 1.71 56.25% | 8.98 425.78% | |
capex per share | -0.02 - | -0.00 82.68% | -0.01 128.95% | -0.05 473.39% | -0.01 69.39% | -0.06 296.88% | -0.06 5.89% | -0.07 14.15% | -0.00 97.05% | -0.06 2,543.93% | |
capex to depreciation | -13.67 - | -0.90 93.44% | -1.82 103.40% | -3.94 116.29% | -0.53 86.59% | -3.15 494.92% | -3.21 2.13% | -6.64 106.80% | -0.20 96.92% | -0.57 176.67% | |
capex to operating cash flow | 0.01 - | 0.00 68.89% | 0.00 34.63% | -0.46 11,179.80% | 0.01 101.13% | 0.02 253.17% | 0.04 90.76% | 0.03 5.99% | 0.00 96.36% | -0.01 1,028.45% | |
capex to revenue | -0.10 - | -0.02 76.04% | -0.10 323.87% | -0.03 71.17% | -0.50 1,663.98% | -0.04 - | |||||
cash per share | 4.16 - | 4.31 3.67% | 3.07 28.65% | 6.76 119.79% | 9.56 41.54% | 10.44 9.12% | 6.11 41.47% | 3.39 44.54% | 1.89 44.14% | 28.45 1,403.61% | |
days of inventory on hand | 0.00 - | ||||||||||
days payables outstanding | 373.92 - | ||||||||||
days sales outstanding | 92.01 - | 59.91 34.88% | 77.15 28.77% | 5.68 92.64% | 19.61 245.53% | 2.19 - | |||||
debt to assets | 0.04 - | 0.04 0.92% | 0.03 5.21% | 0.03 0.43% | 0.01 73.93% | ||||||
debt to equity | 0.04 - | 0.04 6.23% | 0.04 8.95% | 0.04 9.34% | 0.03 29.18% | ||||||
dividend yield | |||||||||||
earnings yield | -0.43 - | -0.24 44.20% | -0.21 12.35% | -0.05 74.80% | -0.18 230.13% | -0.18 3.28% | -0.28 52.83% | -1.29 363.64% | -1.46 13.61% | -1.36 7.08% | |
enterprise value | 25.92M - | 90.82M 250.38% | 180.72M 98.99% | 721.17M 299.05% | 474.30M 34.23% | 502.79M 6.01% | 165.02M 67.18% | 61.69M 62.62% | 13.98M 77.34% | 27.54M 97.03% | |
enterprise value over ebitda | -1.08 - | -3.07 183.80% | -4.10 33.53% | -14.03 242.10% | -5.15 63.30% | -4.90 4.96% | -2.58 47.40% | -1.25 51.51% | -0.15 88.10% | -0.43 188.85% | |
ev to operating cash flow | -1.73 - | -4.86 180.60% | -5.18 6.66% | 387.71 7,583.22% | -7.30 101.88% | -5.98 18.09% | -2.62 56.17% | -0.66 74.80% | -0.17 74.94% | 1.21 831.72% | |
ev to sales | 79.96 - | 32.04 59.93% | 31.50 1.69% | 2.09 93.38% | 9.86 372.87% | 3.85 - | |||||
free cash flow per share | -2.16 - | -1.19 44.72% | -2.03 70.24% | 0.06 102.76% | -2.86 5,206.14% | -3.26 13.86% | -1.84 43.58% | -2.23 21.18% | -1.75 21.65% | 4.91 381.24% | |
free cash flow yield | -0.27 - | -0.16 42.15% | -0.17 5.23% | 0.00 100.74% | -0.13 10,314.54% | -0.16 25.88% | -0.30 90.81% | -0.96 214.66% | -1.34 40.43% | 0.50 137.16% | |
graham net net | 2.35 - | 3.35 42.80% | 2.02 39.90% | 3.69 82.98% | 7.13 93.24% | 7.99 12.15% | 4.93 38.32% | 2.88 41.54% | 1.51 47.55% | 7.41 389.96% | |
graham number | 25.30 - | 17.56 30.59% | 16.37 6.75% | 18.60 13.58% | 28.76 54.67% | 29.50 2.57% | 16.02 45.69% | 16.23 1.31% | 8.55 47.34% | 51.98 508.10% | |
income quality | 0.63 - | 0.66 4.40% | 0.79 19.93% | -0.04 105.51% | 0.72 1,747.33% | 0.86 20.29% | 1.01 17.64% | 0.72 29.00% | 0.91 26.15% | -0.37 140.94% | |
intangibles to total assets | 0.59 - | 0.31 46.87% | 0.42 36.31% | 0.25 42.05% | 0.16 36.84% | 0.12 21.14% | 0.15 20.00% | 0 100% | 0 | 0 | |
interest coverage | 188.98 - | ||||||||||
interest debt per share | 0.47 - | 0.29 38.80% | 0.15 47.67% | 0.06 59.04% | 0.27 334.86% | ||||||
inventory turnover | 450K - | ||||||||||
invested capital | 0.04 - | 0.04 6.23% | 0.04 8.95% | 0.04 9.34% | 0.03 29.18% | ||||||
market cap | 55.01M - | 117.93M 114.37% | 209.30M 77.48% | 803.20M 283.76% | 515.77M 35.79% | 537.25M 4.16% | 214.33M 60.11% | 100.84M 52.95% | 62.93M 37.59% | 45.04M 28.43% | |
net current asset value | 16.56M - | 53.37M 222.21% | 35.33M 33.79% | 66.93M 89.43% | 165.11M 146.67% | 216.09M 30.88% | 181.82M 15.86% | 132.07M 27.36% | 77.84M 41.07% | 37.41M 51.93% | |
net debt to ebitda | 1.21 - | 0.92 24.53% | 0.65 29.27% | 1.60 146.11% | 0.45 71.79% | 0.34 25.49% | 0.77 129.34% | 0.79 2.96% | 0.52 34.35% | 0.27 47.59% | |
net income per share | -3.40 - | -1.81 46.69% | -2.57 41.80% | -2.41 6.14% | -3.98 65.03% | -3.72 6.58% | -1.68 54.81% | -3.00 78.56% | -1.90 36.61% | -13.38 603.30% | |
operating cash flow per share | -2.14 - | -1.19 44.34% | -2.02 70.06% | 0.10 105.18% | -2.85 2,818.58% | -3.20 12.38% | -1.78 44.49% | -2.16 21.43% | -1.74 19.15% | 4.97 384.77% | |
payables turnover | 0.98 - | ||||||||||
receivables turnover | 3.97 - | 6.09 53.57% | 4.73 22.34% | 64.31 1,259.34% | 18.61 71.06% | 166.58 - | |||||
research and ddevelopement to revenue | 4.90 - | 4.91 0.20% | 5.37 9.33% | 1.35 74.86% | 10.96 711.38% | 6.83 - | |||||
return on tangible assets | -0.81 - | -0.31 61.71% | -0.78 153.67% | -0.34 57.21% | -0.40 19.54% | -0.33 18.34% | -0.25 24.73% | -0.68 175.86% | -0.90 33.08% | -0.45 50.76% | |
revenue per share | 0.51 - | 0.65 27.78% | 0.61 6.37% | 2.23 267.31% | 0.14 93.53% | 1.56 - | |||||
roe | -0.41 - | -0.24 41.00% | -0.55 131.24% | -0.38 31.70% | -0.43 13.84% | -0.36 17.05% | -0.25 30.76% | -0.77 210.66% | -1.11 44.89% | -1.49 33.76% | |
roic | -0.41 - | -0.24 41.52% | -0.56 133.71% | -0.38 31.83% | -0.45 16.92% | -0.34 23.20% | -0.24 30.50% | -0.72 200.85% | -1.04 45.18% | -1.49 43.32% | |
sales general and administrative to revenue | 1.89 - | 2.35 24.55% | 2.06 12.27% | 0.47 77.28% | 4.60 882.32% | ||||||
shareholders equity per share | 8.37 - | 7.56 9.64% | 4.64 38.68% | 6.37 37.43% | 9.24 44.97% | 10.40 12.62% | 6.79 34.73% | 3.90 42.52% | 1.71 56.25% | 8.98 425.78% | |
stock based compensation to revenue | 0.95 - | 1.92 101.75% | 1.29 33.07% | 0.28 78.55% | 0.84 203.12% | ||||||
tangible asset value | 16.83M - | 77.10M 358.03% | 38.24M 50.40% | 71.48M 86.93% | 169.01M 136.45% | 231.58M 37.02% | 198.94M 14.09% | 168.93M 15.09% | 82.66M 51.07% | 41.10M 50.28% | |
tangible book value per share | 2.41 - | 4.91 104.15% | 2.22 54.79% | 4.03 81.41% | 7.41 84.07% | 8.82 18.98% | 5.62 36.33% | 3.90 30.49% | 1.71 56.25% | 8.98 425.78% | |
working capital | 28.16M - | 64.97M 130.68% | 46.45M 28.49% | 109.63M 135.99% | 204.03M 86.11% | 258.34M 26.62% | 200.06M 22.56% | 138.13M 30.96% | 80.67M 41.60% | 94.56M 17.22% |
All numbers in USD (except ratios and percentages)